HUYA Bioscience International Competitors and Similar CompaniesClear all

HUYA Bioscience International's competitors and similar companies include Genocea Biosciences, La Jolla Pharmaceutical Company, Nykode Therapeutics and Celltrion Healthcare.

	HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products.	Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.	La Jolla Pharmaceutical Company La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.	Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies.	Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
Founding Date	Founding Date 2004	Founding Date 2006	Founding Date 1989	Founding Date 2007	Founding Date 2002
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more	Locations Cambridge, US HQ	Locations San Diego, US HQ San Diego, US San Diego, US	Locations Oslo, NO HQ	Locations Incheon, KR HQ
Employees	Employees 1113% increase	Employees 593% decrease	Employees 9047% decrease	Employees 135	Employees 6301% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 5.7 k	Valuation ($) 171.2 m	Valuation ($) 144.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.6m (FY, 2021)	Revenue (est.) $75.7m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) ₩2t (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.3m (FY, 2025)	Cost of goods ₩1.4t (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ($801k) (FY, 2025)	Gross profit ₩664.7b (FY, 2022)
Net income	Net income N/A	Net income ($33.2m) (FY, 2021)	Net income $19.7m (FY, 2021)	Net income ($12.2m) (FY, 2025)	Net income ₩147.2b (FY, 2022)
Funding
Total funding raised	Total funding raised $ 12.6m	Total funding raised $ 209.5m	Total funding raised $ 22.9m	Total funding raised $ 31.5m	Total funding raised N/A